Afelimomab
Product Specifications
CAS Number
156227-98-4
Target
TNF
Related Pathways
Apoptosis
Bioactivity
Afelimomab (MAK 195F), a F (ab') 2 fragment of an anti-tumor necrosis factor monoclonal antibody, is utilized in sepsis research [1].
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
CSB-MP005998HU1-01 10 µg
Recombinant Human Cytotoxic and regulatory T-cell molecule (CRTAM), partial
Sign In for Pricing
View Details CSB-MP005998HU1-02 50 µg
Recombinant Human Cytotoxic and regulatory T-cell molecule (CRTAM), partial
Sign In for Pricing
View Details CSB-MP005998HU1-03 200 µg
Recombinant Human Cytotoxic and regulatory T-cell molecule (CRTAM), partial
Sign In for Pricing
View Details CSB-MP005998HU1-04 500 µg
Recombinant Human Cytotoxic and regulatory T-cell molecule (CRTAM), partial
Sign In for Pricing
View Details CSB-MP005998HU1-05 20 µg
Recombinant Human Cytotoxic and regulatory T-cell molecule (CRTAM), partial
Sign In for Pricing
View Details CSB-MP005998HU1-06 100 µg
Recombinant Human Cytotoxic and regulatory T-cell molecule (CRTAM), partial
Sign In for Pricing
View Details